• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非处方药治疗下尿路症状的男性的特征。

Characteristics of men using non-prescription medicines to treat their lower urinary tract symptoms.

作者信息

Michel Martin C, Miller Kurt, Schneider Tim, Ude Christian, Oelke Matthias

机构信息

Department of Pharmacology, University Medical Center, Johannes Gutenberg University, Mainz, Germany.

Department of Urology, Charité, Berlin, Germany.

出版信息

World J Urol. 2025 May 8;43(1):283. doi: 10.1007/s00345-025-05560-1.

DOI:10.1007/s00345-025-05560-1
PMID:40338280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12062051/
Abstract

PURPOSE

Many men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) opt for self-management with non-prescription treatments. We wished to better characterize these men and understand their motivation and experience.

METHODS

We conducted an anonymous survey among 477 users of non-prescription treatments for LUTS.

RESULTS

Participating men had a mean age (64.3 ± 7.8 years) and IPSS (17.7 ± 7.9 points) comparable to users of prescription medicines in non-interventional studies, indicating that they were not primarily motivated by mild symptom intensity. They had realistic expectations on efficacy and tolerability. While reasons for preference for a non-prescription treatment varied, 40.0% stated a wish to avoid 'chemical' and, vice-versa, to use 'natural' treatments. The choice of a specific treatment was largely driven by prior experience, but recommendations from a physician or the pharmacy as well as advertisements also played a role. About two thirds of participants reported to be repeat users and purchasing the same product each time. However, less than a quarter of participants appear to use the non-prescription treatment continuously.

CONCLUSIONS

Men self-managing their LUTS/BPH are similar to those using prescription drugs based on age and symptom severity. Their main reasons to prefer non-prescription medicines relate to the wish to avoid 'chemical' and the preference for 'natural' treatments. Most of them are repeat users of the same product but use it only intermittently.

摘要

目的

许多有提示良性前列腺增生的下尿路症状(LUTS/BPH)的男性选择使用非处方治疗进行自我管理。我们希望更好地描述这些男性的特征,并了解他们的动机和经历。

方法

我们对477名使用非处方治疗LUTS的用户进行了匿名调查。

结果

参与调查的男性的平均年龄(64.3±7.8岁)和国际前列腺症状评分(IPSS,17.7±7.9分)与非干预研究中使用处方药的用户相当,这表明他们并非主要受轻度症状强度的驱使。他们对疗效和耐受性有现实的期望。虽然选择非处方治疗的原因各不相同,但40.0%的人表示希望避免使用“化学”药物,反之,希望使用“天然”治疗。具体治疗方法的选择很大程度上取决于既往经验,但医生或药房的推荐以及广告也起到了一定作用。约三分之二的参与者报告称是重复使用者,并且每次都购买相同的产品。然而,不到四分之一的参与者似乎持续使用非处方治疗。

结论

自我管理LUTS/BPH的男性在年龄和症状严重程度方面与使用处方药的男性相似。他们更喜欢非处方药的主要原因是希望避免使用“化学”药物以及对“天然”治疗的偏好。他们中的大多数是同一产品的重复使用者,但只是间歇性地使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/12062051/948f01336fcc/345_2025_5560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/12062051/948f01336fcc/345_2025_5560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c2e/12062051/948f01336fcc/345_2025_5560_Fig1_HTML.jpg

相似文献

1
Characteristics of men using non-prescription medicines to treat their lower urinary tract symptoms.使用非处方药治疗下尿路症状的男性的特征。
World J Urol. 2025 May 8;43(1):283. doi: 10.1007/s00345-025-05560-1.
2
Characteristics of men with untreated LUTS interested in over-the-counter tamsulosin.对非处方坦索罗辛感兴趣的未经治疗的下尿路症状男性的特征。
Can J Urol. 2019 Aug;26(4):9821-9828.
3
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.他达拉非每日一次治疗男性下尿路症状(LUTS)合并良性前列腺增生(BPH)而无勃起功能障碍。
BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13.
4
Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.有症状的良性前列腺增生男性下尿路症状的严重程度反映了膀胱储尿功能障碍和膀胱出口梗阻的不同构成。
Int J Clin Pract. 2014 Jun;68(6):743-8. doi: 10.1111/ijcp.12364. Epub 2014 Jan 29.
5
Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.炎症是治疗与良性前列腺增生相关的下尿路症状的医学靶点。
World J Urol. 2020 Nov;38(11):2771-2779. doi: 10.1007/s00345-020-03106-1. Epub 2020 Feb 14.
6
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.前列腺内注射肉毒毒素 A 治疗良性前列腺增生所致下尿路症状(LUTS)男性患者的患者报告结局:一项前瞻性单臂队列研究的 3 个月结果。
BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19.
7
Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.每日一次坦索罗辛 5 毫克治疗伴或不伴勃起功能障碍的下尿路症状提示良性前列腺增生症男性的疗效:自然观察性 TadaLutsEd 研究结果。
J Sex Med. 2014 Feb;11(2):498-505. doi: 10.1111/jsm.12386. Epub 2013 Nov 13.
8
Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.勃起功能障碍与良性前列腺增生相关的下尿路症状(LUTS/BPH)在接受他达拉非治疗12周后联合有效。
BJU Int. 2016 Jul;118(1):153-60. doi: 10.1111/bju.13406. Epub 2016 Feb 11.
9
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.前列腺素途径在接受药物治疗失败的良性前列腺增生症伴下尿路症状患者中被激活。
Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20.
10
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.用于治疗与良性前列腺增生相关的下尿路症状的磷酸二酯酶抑制剂。
Cochrane Database Syst Rev. 2018 Nov 16;11(11):CD010060. doi: 10.1002/14651858.CD010060.pub2.

本文引用的文献

1
Natural Products in the Treatment of Lower Urinary Tract Dysfunction and Infection.天然产物在治疗下尿路功能障碍和感染中的应用
Handb Exp Pharmacol. 2025;287:295-323. doi: 10.1007/164_2024_708.
2
[Conservative and pharmacological treatment of benign prostatic hyperplasia : The German S2e-guideline 2023-part2].[良性前列腺增生的保守及药物治疗:2023年德国S2e指南 - 第二部分]
Urologie. 2023 Oct;62(10):1048-1056. doi: 10.1007/s00120-023-02183-5. Epub 2023 Oct 5.
3
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.
2023 年欧洲泌尿外科学会关于非神经源性男性下尿路症状管理指南的总结论文。
Eur Urol. 2023 Aug;84(2):207-222. doi: 10.1016/j.eururo.2023.04.008. Epub 2023 May 17.
4
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.坦索罗辛联合刺蒺藜正己烷提取物与坦索罗辛联合5α-还原酶抑制剂治疗中重度下尿路症状伴良性前列腺增生患者6个月的疗效和耐受性:一项配对匹配临床研究的结果
J Clin Med. 2022 Jun 22;11(13):3615. doi: 10.3390/jcm11133615.
5
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology.实验生物学中展示数据和报告数据分析及统计方法的新作者指南。
Drug Metab Dispos. 2020 Jan;48(1):64-74. doi: 10.1124/dmd.119.090027.
6
Scientists rise up against statistical significance.科学家们奋起反对统计显著性。
Nature. 2019 Mar;567(7748):305-307. doi: 10.1038/d41586-019-00857-9.
7
Research Needs to Understand Self-Management of Lower Urinary Tract Symptoms: Summary of NIDDK Workshop.了解下尿路症状自我管理的研究需求:美国国立糖尿病、消化和肾脏疾病研究所研讨会总结
J Urol. 2018 Jun;199(6):1408-1410. doi: 10.1016/j.juro.2017.11.079. Epub 2017 Dec 2.
8
Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population.老年人群下尿路症状的患病率及进展情况
Urology. 2016 Sep;95:158-63. doi: 10.1016/j.urology.2016.06.021. Epub 2016 Jun 23.
9
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.良性前列腺增生相关下尿路症状患者的生活质量:根据治疗情况在现实生活中的随时间变化——QUALIPROST研究
Int Urol Nephrol. 2016 May;48(5):645-56. doi: 10.1007/s11255-015-1206-7. Epub 2016 Jan 25.
10
Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study.加利福尼亚男性健康研究中男性下尿路症状(LUTS)的进展和治疗。
BJU Int. 2015 Jan;115(1):127-33. doi: 10.1111/bju.12810. Epub 2014 Aug 16.